drugset / Trial / NCT06060015

Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section

NCT06060015 ↗

Phase 4 Unknown 106 enrolled Hospital Civil de Guadalajara
RandomizedParallel-groupDouble-blindSupportive care

Summary

Evaluates the effect of hyperbaric subarachnoid bupivacaine at doses of 5 mg vs 10 mg on mean arterial pressure in obese pregnant patients undergoing cesarean section

Timeline

Start
2023-08-01
Primary completion
2024-10-31
Completion
2024-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 5 mg Other
Subject Bupivacaine Other / unclassified 10 mg Other

Indications

No indication recorded.